← All Newamsterdam Pharma CO NV filings

Newamsterdam Pharma CO NV Form 4 insider transactions

NASDAQ
NAMS
Newamsterdam Pharma CO NV
Form 4: NewAmsterdam Pharma Director James N. Topper Acquires Shares
Director James N. Topper reports acquisition of NewAmsterdam Pharma Co N.V. shares through Frazier Life Sciences.
NASDAQ
NAMS
Newamsterdam Pharma CO NV
Form 4: NewAmsterdam Pharma Co N.V. Executive Exercises Options, Sells Shares to Cover Tax Obligations
Johannes Jacob Pieter Kastelein, Chief Scientific Officer of NewAmsterdam Pharma Co N.V., exercised options and sold shares to satisfy tax liabilities, as detailed in a recent SEC filing.